Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Preoperative transfusion in patients with sickle-cell disease.

Goldsmith JC, Wang WC.

Lancet. 2013 Mar 16;381(9870):886-8. doi: 10.1016/S0140-6736(12)61995-3. Epub 2013 Jan 23. No abstract available.

PMID:
23352053
2.

The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial.

Howard J, Malfroy M, Llewelyn C, Choo L, Hodge R, Johnson T, Purohit S, Rees DC, Tillyer L, Walker I, Fijnvandraat K, Kirby-Allen M, Spackman E, Davies SC, Williamson LM.

Lancet. 2013 Mar 16;381(9870):930-8. doi: 10.1016/S0140-6736(12)61726-7. Epub 2013 Jan 23.

PMID:
23352054
3.

A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group.

Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, Pegelow C, Abboud M, Ohene-Frempong K, Iyer RV.

N Engl J Med. 1995 Jul 27;333(4):206-13.

4.

[Assessment of the use of transfusion therapy and complications in orthopedic surgery in patients with sickle-cell anemia: retrospective study].

Ould amar AK, Delattre O, Godbille C, Béra O, Halbout PA, Catonné Y.

Transfus Clin Biol. 2003 Apr;10(2):61-6. Review. French.

PMID:
12763144
5.

Preoperative transfusions for patients with sickle cell disease?

[No authors listed]

BMJ. 2013 Jan 30;346:f545. doi: 10.1136/bmj.f545. No abstract available.

PMID:
23364066
6.

Assessment of perioperative transfusion therapy and complications in sickle cell disease patients undergoing surgery.

Al-Samak ZM, Al-Falaki MM, Pasha AA.

Middle East J Anaesthesiol. 2008 Jun;19(5):983-95.

PMID:
18637600
7.

Preoperative management of sickle cell patients.

Georges RN, McDonald JC, Deitch EA.

J La State Med Soc. 1992 Jul;144(7):316-9.

PMID:
1431491
8.

Transient disappearance of sickle hemoglobin after transfusion.

Steinberg MH.

Blood. 1995 Jun 15;85(12):3766-7. No abstract available.

9.
10.

Blood transfusion in sickle cell disease.

Marouf R.

Hemoglobin. 2011;35(5-6):495-502. doi: 10.3109/03630269.2011.596984. Epub 2011 Oct 7.

PMID:
21981466
11.

Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases.

Koshy M, Weiner SJ, Miller ST, Sleeper LA, Vichinsky E, Brown AK, Khakoo Y, Kinney TR.

Blood. 1995 Nov 15;86(10):3676-84.

12.

Sickle cell disease: a review and update of current therapy.

Lawrenz DR.

J Oral Maxillofac Surg. 1999 Feb;57(2):171-8. Review. No abstract available.

PMID:
9973126
13.

The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group.

Vichinsky EP, Neumayr LD, Haberkern C, Earles AN, Eckman J, Koshy M, Black DM.

Am J Hematol. 1999 Nov;62(3):129-38.

14.

Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke.

Rana S, Houston PE, Surana N, Shalaby-Rana EI, Castro OL.

J Pediatr. 1997 Nov;131(5):757-60.

PMID:
9403661
15.

Preoperative exchange transfusion in sickle cell anemia.

Fullerton MW, Philippart AI, Sarnaik S, Lusher JM.

J Pediatr Surg. 1981 Jun;16(3):297-300.

PMID:
7252730
16.

Safe surgery in sickle cell disease.

Banerjee AK, Layton DM, Rennie JA, Bellingham AJ.

Br J Surg. 1991 May;78(5):516-7. Review. No abstract available.

PMID:
2059796
17.

Minor elective surgical procedures using general anesthesia in children with sickle cell anemia without pre-operative blood transfusion.

Fu T, Corrigan NJ, Quinn CT, Rogers ZR, Buchanan GR.

Pediatr Blood Cancer. 2005 Jul;45(1):43-7.

PMID:
15880471
18.

Assessment of the use of transfusion therapy perioperatively in patients with sickle cell hemoglobinopathies.

Bischoff RJ, Williamson A 3rd, Dalali MJ, Rice JC, Kerstein MD.

Ann Surg. 1988 Apr;207(4):434-8.

19.

Open heart surgery in patients with sickle cell hemoglobinopathy.

Yousafzai SM, Ugurlucan M, Al Radhwan OA, Al Otaibi AL, Canver CC.

Circulation. 2010 Jan 5;121(1):14-9. doi: 10.1161/CIRCULATIONAHA.109.882464. Epub 2009 Dec 21.

20.

Feasibility and benefit of hydroxycarbamide as a long-term treatment for sickle cell disease patients: results from the North West London Sickle Cell Disease Registry.

Gilmore A, Cho G, Howard J, Layton M, Afif M, Hughes RG, Philpott NJ, Patankar S, Davies SC; North West London Haemoglobinopathy Registry Group.

Am J Hematol. 2011 Nov;86(11):958-61. doi: 10.1002/ajh.22146. Epub 2011 Sep 21. No abstract available.

Supplemental Content

Support Center